Stay updated with breaking news from Michael Welsh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cystetic Medicines, Inc., a clinical-stage biotechnology company developing small molecule channels that serve as molecular prosthetics for missing or dysfunctional CFTR protein channels, announced today that the first healthy volunteer has been dosed with CM001 in a Phase 1 clinical trial. CM001 is a molecular prosthetic intended to treat people with cystic fibrosis (CF).
Clinical testing is underway for a potentially groundbreaking new treatment for cystic fibrosis. Pioneered by scientists at Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign and the Carver College of Medicine at the University of Iowa in partnership with the spin-out biotechnology company, cystetic Medicines, this promising inhalable molecular prosthetic is intended to improve lung function in people with CF who cannot benefit from current therapies.
Rural Fire Service Queensland is predicting an early start to the 2023-24 fire season with the main risk...
There are questions I would put to South Portland in reference to the banning of gas mowers and leaf blowers. How many mowers, weed whackers, leaf blowers and snow blowers does the city currently have? Are they all electric? I doubt it. What is the city’s plan to replace them? More taxes? Making us residents […]
Common Pleas New Cases Matthew Merriman, Steubenville, and Sara Merriman, Water Street, Salineville; dissolution sought. Homer Smith, Chestnut Street, Lee